[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

The US Oncology Network - Strategic SWOT Analysis Review

June 2021 | 30 pages | ID: U12368065B4EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

The US Oncology Network (US Oncology) formerly US Oncology Inc is an integrated oncology network formed by community-based oncology physicians and clinicians focused on advancing cancer care. The organization, by utilizing the information technology, refined evidence-based medicine guidelines, shared best practices and quality measurements, improve patient outcomes and advance the quality, safety and science of cancer care. It offers iknowMed, an oncology-specific electronic health record (EHR), developed by oncologists to meet the unique needs of oncology practices, and cancer patients. It is a subsidiary of McKesson Corporation. US Oncology is headquartered in Woodlands, Texas, the US.

The US Oncology Network Key Recent Developments

Jun 03,2021: US Oncology Research, The US Oncology Network and Ontada announce clinical data showcased in plenary and oral sessions at ASCO Annual Meeting
Apr 01,2021: The US Oncology Network continues its rapid growth and enhances surgical expertise with addition of physicians from Texas Colon & Rectal Specialists as a part of Texas Oncology
Oct 22,2020: The US Oncology Network continues to grow, enhancing community cancer care by welcoming two more practices

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

The US Oncology Network - Key Facts
The US Oncology Network - Key Employees
The US Oncology Network - Major Products and Services
The US Oncology Network - History
The US Oncology Network - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
The US Oncology Network - Business Description
The US Oncology Network - SWOT Analysis
SWOT Analysis - Overview
The US Oncology Network - Strengths
The US Oncology Network - Weaknesses
The US Oncology Network - Opportunities
The US Oncology Network - Threats
The US Oncology Network - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

The US Oncology Network, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
The US Oncology Network, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
The US Oncology Network, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Jun 03, 2021: US Oncology Research, The US Oncology Network and Ontada announce clinical data showcased in plenary and oral sessions at ASCO Annual Meeting
Apr 01, 2021: The US Oncology Network continues its rapid growth and enhances surgical expertise with addition of physicians from Texas Colon & Rectal Specialists as a part of Texas Oncology
Oct 22, 2020: The US Oncology Network continues to grow, enhancing community cancer care by welcoming two more practices

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

The US Oncology Network, Key Facts
The US Oncology Network, Key Employees
The US Oncology Network, Major Products and Services
The US Oncology Network, History
The US Oncology Network, Subsidiaries
The US Oncology Network, Joint Venture
The US Oncology Network, Key Competitors
The US Oncology Network, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
The US Oncology Network, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
The US Oncology Network, Recent Deals Summary

LIST OF FIGURES

The US Oncology Network, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
The US Oncology Network, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications